It has been previously reported that activators or blockers of thrombin-activated PAR-1 evoke a decrease and increase in blood pressure in healthy animals, respectively [28], whereas the blockade of PAR-1 in renin-overexpressing mice reduces hypertension [29]. This evidence concerns the gene F2R and Hypertension.